MAPK/Nrf2

Zicheng Wang1, Yingying Yu2, Wanjun Shao3

  • 1Binzhou Medical University/Yantai Affiliated hospital of Binzhou Medical University, Yantai 256600, China; School of pharmacy, Binzhou Medical University, Yantai 264003, China.

概括

普埃拉林 (PR) 通过调节肠道微生物群和减少炎症来改善酒精性肝病 (ALD). 这项研究揭示了PR的PR.